Frank Mir flagged for potential USADA test violation out of UFC Fight Night 85 loss to Mark Hunt

By Jamie Penick, MMATorch Editor-in-Chief

Former UFC Heavyweight Champion Frank Mir has been flagged for a potential anti-doping violation in a test taken the day of his fight with Mark Hunt in Brisbane, Australia last month at UFC Fight Night 85.

The UFC revealed the news in a statement on Friday night.

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Frank Mir of a potential Anti-Doping Policy violation stemming from an in-competition sample collected the day of his fight on March 20, 2016 in Brisbane, Australia.

USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Mir. It is important to note that, under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed.

Additional information will be provided at the appropriate time as the process moves forward.

Mir, who was knocked out by Hunt in that main event fight in Brisbane, will have an opportunity to address the alleged violation, have his b-sample tested, and/or appeal whatever sanction is imposed.

Penick’s Analysis: It wouldn’t be surprising in the least if Mir was using something at his age and at this stage of his career. Getting caught doesn’t happen all the time, especially in fight day tests, but he’s not among the handful of names whose positive tests would truly come as a surprise.

[Photo (c) Matt Roberts via USA Today Sports]

Attention iPhone/iPad and Android users, if you’ve enjoyed our app in the past and followed us there, or if you’ve never checked it out, make sure to update to the latest version in the Apple store and/or Google Play store. We’ve launched a new look for the app, in line with our recent desktop overhaul. Make sure to check it out!

For current App users, swipe right to view next article, swipe left to view previous article.

Be the first to comment

Leave a Reply

Your email address will not be published.